Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)

China · Delayed Price · Currency is CNY

1.540

-0.010 (-0.65%)

Sep 10, 2026, 2:10 PM CST

Market Cap	4.08B -40.6%
Revenue (ttm)	23.66B -15.5%
Net Income	-798.69M
EPS	-0.30
Shares Out	2.63B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,161,764
Open	1.550
Previous Close	1.550
Day's Range	1.500 - 1.550
52-Week Range	1.270 - 5.700
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHE:000078

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, manufacturing, and distribution of pharmaceuticals in China. The company also provides distribution of medical devices, and other medical supplies, as well as related value-added services. It serves medical institutions, drug retailers, and distributors. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1992

Employees 6,734

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000078

Full Company Profile

Financial Performance

In 2025, SHE:000078's revenue was 26.67 billion, a decrease of -12.04% compared to the previous year's 30.32 billion. Losses were -563.06 million, -52.82% less than in 2024.

Financial Statements